Vidjongtius - Kalbe Farma Director, Corporate Secretary, IR Contact Officer
| KLBF Stock | IDR 1,250 15.00 1.21% |
Director
Mr. Vidjongtius serves as President Director, IR Contact Officer of PT Kalbe Farma Tbk since June 14, 2017. He was appointed as Director in 1997 and served as Corporationrationrate Secretary from March 28, 2008 until June 14, 2017. He obtained a Bachelor degree in Economics from Universitas Trisakti, Indonesia. In 1985, he began his career at the Public Accountant Firm of Drs. Joseph Susilo Partners, and was also a lecturer at STIE Trisakti. He joined Kalbe in 1990, in the Finance and Accounting Department. In 1996, he was appointed as the Finance Director of PT Dankos Laboratories Tbk., where he served until 1997, and as Director of the Company since 1997. From January 2006 until 2010, he has served as President Director of PT Enseval Putera Megatrading Tbk, the Companys distribution division. since 2017.
| Age | 59 |
| Tenure | 8 years |
| Phone | 62 21 4287 3888 |
| Web | https://www.kalbe.co.id |
Kalbe Farma Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Tje Tjhie | PT Indofood Sukses | 55 | |
| Benny Wendry | Semen Indonesia Persero | 54 | |
| Franciscus Welirang | PT Indofood Sukses | 71 | |
| Taufik Wiraatmadja | PT Indofood Sukses | 65 | |
| Iman Nurwahyu | United Tractors Tbk | 60 | |
| Hendra Widjaja | PT Indofood Sukses | 57 | |
| Johannes Loman | Astra International Tbk | 60 | |
| Doddy Diniawan | Semen Indonesia Persero | 56 | |
| Axton Salim | PT Indofood Sukses | 44 | |
| Joedianto Soejonopoetro | PT Indofood Sukses | 65 | |
| Henry Tanoto | Astra International Tbk | 49 | |
| Suparno Djasmin | Astra International Tbk | 58 | |
| Adi Munandir | Semen Indonesia Persero | 42 | |
| Santosa | Astra International Tbk | 53 | |
| Gidion Hasan | Astra International Tbk | 47 | |
| Tri Abdisatrijo | Semen Indonesia Persero | 54 | |
| Gita Boer | Astra International Tbk | 57 | |
| Paulus Moleonoto | PT Indofood Sukses | 61 | |
| Bambang Santoso | Astra International Tbk | 60 | |
| Tina Intan | Semen Indonesia Persero | 64 | |
| Hernie Raharja | Unilever Indonesia Tbk | 48 | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 |
Kalbe Farma Tbk Leadership Team
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lanny Soputro, G HR | ||
| Vidjongtius, Director, Corporate Secretary, IR Contact Officer | ||
| Kurniawan Suhartono, Head Unit | ||
| Sie Djohan, Management Devel | ||
| Lukito Gozali, Head Relations |
Kalbe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kalbe Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 95.3 T | |||
| Shares Outstanding | 46.26 B | |||
| Shares Owned By Insiders | 58.08 % | |||
| Shares Owned By Institutions | 15.23 % | |||
| Price To Book | 5.06 X | |||
| Price To Sales | 3.36 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.